Untreated Adult Acute Lymphoblastic Leukemia Withdrawn Phase 2 Trials for Prednisone (DB00635)

IndicationStatusPhase
DBCOND0029290 (Untreated Adult Acute Lymphoblastic Leukemia)Withdrawn2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01670084
Nilotinib and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia or Blastic Phase Chronic Myelogenous LeukemiaTreatment